Search Results

Gen Content Modern

Gen Content Modern Biobehavioral Oncology Research Program Understanding how psychosocial factors impact outcomes for children, adolescents and young...

Table of Contents

2018 Pediatric Bioethics Conference When Cultures Clash: Nav igating Ethical Disagreements Related to Diversity Christopher Patin Christopher Patin,...

PE2904S Adolescent and Young Adult Diabetes Program-Spanish

Adolescent and Young Adult Diabetes Program / Spanish Programa de Diabetes para adolescentes y adultos jóvenes El Programa de Diabetes para...

Hepatology Program - Seattle Children's

The Seattle Children’s Hepatology Program diagnoses and treats the full range of liver disease in children ages birth to 21.

PE667 Ultrasound

Ultrasound What an ultrasound room looks like What is an ultrasound? An ultrasound is an exam that uses sound waves to view and make pictures, or...

PE185S Protecting My Child's Heart and Lungs from Secondhand Smoke - Spanish

Protecting My Child’s Heart and Lungs from Secondhand and Thirdhand Smoke / Spanish Cómo proteger el corazón y los pulmones de mi hijo del humo de...

ContRelease925

ContRelease925 Test Email Address Text Next Questions Text Submit Previous step Step 1/ 2 Next step

Darcy D King, ARNP

Darcy D King, ARNP specializing in Neurodevelopmental Pediatrics, Craniofacial Center, Turner Syndrome

PE185 Protecting My Child's Heart and Lungs from Secondhand Smoke

Protecting My Child’s Heart and Lungs from Secondhand and Thirdhand Smoke What is secondhand smoke? Secondhand smoke is smoke in the air that was...

An open-label ascending dose cohort study to assess the safety, pharmacokinetics, and preliminary efficacy of neoGAA (GZ402666) in patients with infantile-onset Pompe disease treated with alglucosidase alfa who demonstrate clinical decline o-STUDY00000893

This is a drug study to evaluate the safety of neoGAA in patients with infantile-onset Pompe Disease previously treated with alglucosidase alfa....